+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review

Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and markets a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio consists of medicines to treat gynaecological diseases, cardiovascular diseases, gastrointestinal diseases, and central nervous system disorders. Richter’s research activities focus exclusively on the development of original small molecules, recombinant biotechnology, and generic product development. It operates sales network in Hungary, Central Eastern Europe, and the Commonwealth of Independent States (CIS) countries. The company has a research and development unit in Central Eastern Europe. Richter is headquartered in Budapest, Hungary.

Richter Gedeon Nyrt Key Recent Developments
  • Apr 22, 2020: Richter’s response to COVID-19 pandemic

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Richter Gedeon Nyrt - Key Facts
  • Richter Gedeon Nyrt - Key Employees
  • Richter Gedeon Nyrt - Key Employee Biographies
  • Richter Gedeon Nyrt - Major Products and Services
  • Richter Gedeon Nyrt - History
  • Richter Gedeon Nyrt - Company Statement
  • Richter Gedeon Nyrt - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture

Section 2 - Company Analysis
  • Company Overview
  • Richter Gedeon Nyrt - Business Description
  • Business Segment: Other
  • Overview
  • Performance
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Wholesale and Retail
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: China
  • Performance
  • Geographical Segment: CIS
  • Performance
  • Geographical Segment: European Union
  • Performance
  • Geographical Segment: Hungary
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: Rest of the World
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Richter Gedeon Nyrt - Corporate Strategy
  • Richter Gedeon Nyrt - SWOT Analysis
  • SWOT Analysis - Overview
  • Richter Gedeon Nyrt - Strengths
  • Richter Gedeon Nyrt - Weaknesses
  • Richter Gedeon Nyrt - Opportunities
  • Richter Gedeon Nyrt - Threats
  • Richter Gedeon Nyrt - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Richter Gedeon Nyrt, Recent Deals Summary

Section 5 - Company’s Recent Developments
  • Apr 22, 2020: Richter’s response to COVID-19 pandemic

Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer

List of Tables
  • Richter Gedeon Nyrt, Key Facts
  • Richter Gedeon Nyrt, Key Employees
  • Richter Gedeon Nyrt, Key Employee Biographies
  • Richter Gedeon Nyrt, Major Products and Services
  • Richter Gedeon Nyrt, History
  • Richter Gedeon Nyrt, Other Locations
  • Richter Gedeon Nyrt, Subsidiaries
  • Richter Gedeon Nyrt, Joint Venture
  • Richter Gedeon Nyrt, Key Competitors
  • Richter Gedeon Nyrt, Ratios based on current share price
  • Richter Gedeon Nyrt, Annual Ratios
  • Richter Gedeon Nyrt, Interim Ratios
  • Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Richter Gedeon Nyrt, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Richter Gedeon Nyrt, Performance Chart (2016 - 2020)
  • Richter Gedeon Nyrt, Ratio Charts
  • Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sinnex Plc
  • Sager Pharma Kft
  • Polfa Hungaria Kft.
  • PannonPharma Pharmaceutical Ltd
  • Nutex Nyrt
  • EGIS Pharmaceuticals Plc